Experienced in Alpha-1 Antitrypsin Deficiency (AATD)

Dr. Maria C. Mascolo

Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Effingham Rehab Services, LLC
123 Canal St, Suite 203, 
Pooler, GA 
 (2197.7 mi)
Accepting New Patients
Offers Telehealth
Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Effingham Rehab Services, LLC
123 Canal St, Suite 203, 
Pooler, GA 
 (2197.7 mi)
OverviewInsuranceLocationsClinical Research

Overview

Maria Mascolo is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Pooler, Georgia. Dr. Mascolo and is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, and Bullae. Dr. Mascolo is currently accepting new patients.

Her clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Sleep Medicine
Licenses
Internal Medicine in GA
Hospital Affiliations
Candler Hospital
East Georgia Regional Medical Center
Effingham Health System
Optim Medical Center - Screven
St Joseph's Hospital - Savannah
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Blue Cross Blue Shield
  •  Anthem
  •  Friday Health
  •  Alliant Health
  •  CareSource
View 1 More Insurance +

Locations

EFFINGHAM REHAB SERVICES, LLC
123 Canal St, Suite 203, Pooler, GA 31322
Other Locations
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
131 Silverwood Ct, Suite 100, Rincon, GA 31326
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
215 Mims Rd, Sylvania, GA 30467
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
800 E 68th St, Savannah, GA 31405
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
1 Meadows Pkwy, Vidalia, GA 30474
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
340 Hodgson Ct, Savannah, GA 31406
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
865 S 1st St, Jesup, GA 31545
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
601 E General Stewart Way, Hinesville, GA 31313
SOUTHEAST LUNG AND CRITICAL CARE SPECIALISTS PC
5353 Reynolds St, Savannah, GA 31405

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: December 17, 2024
Intervention Type: Drug, Biological
Study Drug: GSK3511294
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients
A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients
Enrollment Status: Terminated
Publish Date: September 22, 2022
Intervention Type: Device
Study Phase: Not Applicable
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Enrollment Status: Completed
Publish Date: February 15, 2021
Intervention Type: Other
View 5 Less Clinical Trials
Similar Doctors
Advanced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Andrew V. Cichelli
Pulmonary Medicine | Sleep Medicine
Advanced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Andrew V. Cichelli
Pulmonary Medicine | Sleep Medicine

East Georgia Hma Physician Management LLC

1497 Fair Rd, Suite 102, 
Statesboro, GA 
 (35.7 mi)
912-486-1676
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Cichelli is a Pulmonary Medicine specialist and a Sleep Medicine provider in Statesboro, Georgia. Dr. Cichelli and is rated as a Distinguished provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Lung Metastases, Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Advanced Bronchoscopy, and Gastrostomy. Dr. Cichelli is currently accepting new patients.

Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Peter N. Manos
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine
Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Peter N. Manos
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine

Musc Community Physicians

989 Ribaut Rd, Suite 340, 
Beaufort, SC 
 (38.4 mi)
843-521-8484
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Peter Manos is a Pulmonary Medicine specialist and a Sleep Medicine provider in Beaufort, South Carolina. Dr. Manos and is rated as a Distinguished provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, Pneumonia, and Advanced Bronchoscopy. Dr. Manos is currently accepting new patients.

Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Adewumi O. Oguntunmibi
Pulmonary Medicine
Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Adewumi O. Oguntunmibi
Pulmonary Medicine
411 Stephenson Ave, 
Savannah, GA 
 (12.0 mi)
Languages Spoken:
English, Yoruba
See accepted insurances
Accepting New Patients
Offers Telehealth

Adewumi Oguntunmibi is a Pulmonary Medicine provider in Savannah, Georgia. Dr. Oguntunmibi and is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Bronchitis, Sarcoidosis, Neurosarcoidosis, Advanced Bronchoscopy, and Gastrostomy. Dr. Oguntunmibi is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile